These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38189762)

  • 1. The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.
    Armstrong N; Apkon S; Berggren KN; Braun C; Ciafaloni E; Connolly A; Kennedy A; Kuntz N; Mathews K; McGuire M; Parad R; Scavina M; Scharf RJ; Waldrop M
    J Neuromuscul Dis; 2024; 11(2):525-533. PubMed ID: 38189762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities.
    Kumar SH; Athimoolam K; Suraj M; Das Christu Das MS; Muralidharan A; Jeyam D; Ashokan J; Karthikeyan P; Krishna R; Khanna-Gupta A; Bremadesam Raman L
    PLoS One; 2020; 15(6):e0232654. PubMed ID: 32559196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Lloyd-Puryear M
    Muscle Nerve; 2013 Jul; 48(1):21-6. PubMed ID: 23716304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care.
    Armstrong N; Schrader R; Fischer R; Crossnohere N
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):162-168. PubMed ID: 35932090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy.
    Beckers P; Caberg JH; Dideberg V; Dangouloff T; den Dunnen JT; Bours V; Servais L; Boemer F
    Sci Rep; 2021 Feb; 11(1):3011. PubMed ID: 33542429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy.
    Gruber D; Lloyd-Puryear M; Armstrong N; Scavina M; Tavakoli NP; Brower AM; Caggana M; Chung WK
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):197-205. PubMed ID: 36152336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies.
    Sheikh O; Yokota T
    Expert Opin Investig Drugs; 2021 Feb; 30(2):167-176. PubMed ID: 33393390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Duchenne Muscular Dystrophy: Unlocking the Opportunities in Countries in the Middle East and Beyond.
    Elbashir H; Fathalla W; Mundada V; Iqbal M; Al Tawari AA; Chandratre S; Bastaki L; Romany I; Ismayl O; Abou Tayoun A
    J Neuromuscul Dis; 2022; 9(6):787-801. PubMed ID: 36245386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it the right time for an infant screening for Duchenne muscular dystrophy?
    Vita GL; Vita G
    Neurol Sci; 2020 Jul; 41(7):1677-1683. PubMed ID: 32112218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: Implications of early diagnosis.
    Takeuchi F; Komaki H; Yamagata Z; Maruo K; Rodger S; Kirschner J; Kubota T; Kimura E; Takeda S; Gramsch K; Vry J; Bushby K; Lochmüller H; Wada K; Nakamura H
    Neuromuscul Disord; 2017 Oct; 27(10):894-904. PubMed ID: 28807665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy].
    Bernert G; Hahn A; Köhler C; Meyer S; Schara U; Schlachter K; Trollmann R; Walter MC
    Nervenarzt; 2021 Apr; 92(4):359-366. PubMed ID: 33215271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.
    Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M;
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of Duchenne muscular dystrophy: the state of the art.
    Messina S; Vita GL
    Neurol Sci; 2018 Nov; 39(11):1837-1845. PubMed ID: 30218397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy.
    Mann JR; Zhang Y; McDermott S; Wang Y; Cai B; Conway KM; Paramsothy P; Royer J; Venkatesh S; Howard JF; Ciafaloni E;
    Neuroepidemiology; 2023; 57(2):90-99. PubMed ID: 36623491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.
    Ke Q; Zhao ZY; Griggs R; Wiley V; Connolly A; Kwon J; Qi M; Sheehan D; Ciafaloni E; Howell RR; Furu P; Sazani P; Narayana A; Gatheridge M
    World J Pediatr; 2017 Jun; 13(3):197-201. PubMed ID: 28466241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of Duchenne muscular dystrophy in the Middle East: expert report.
    Jumah MA; Muhaizea MA; Rumayyan AA; Saman AA; Shehri AA; Cupler E; Jan M; Madani AA; Fathalla W; Kashyape P; Kodavooru G; Thihli KA; Bastaki L; Megarbane A; Skrypnyk C; Zamani G; Tuffery-Giraud S; Urtizberea A; Ortez González CI
    Neurodegener Dis Manag; 2019 Jun; 9(3):123-133. PubMed ID: 31166138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.